We have located links that may give you full text access.
One-stage and two-stage meta-analysis of individual participant data led to consistent summarized evidence: lessons learned from combining multiple databases.
Journal of Clinical Epidemiology 2018 March
OBJECTIVE: Combining multiple health-care databases (DBs) allows comparing the effects of a wide variety of health-care services. There is a growing interest in methods for combining the results from multiple DBs. We attempted to learn lessons about the performance of one- and two-stage approaches from the reanalysis of data drawn from two studies of pharmacoepidemiology based on multiple DBs.
STUDY DESIGN AND SETTING: Two nested case-control studies were carried out for estimating the tricyclic antidepressants (TCAs)-arrhythmia and etoricoxib-heart failure associations, respectively, from the Italian Group for Appropriate Drug Prescription in the Elderly and the European Safety of Non-Steroidal Anti-Inflammatory programs. The associations of interest were modeled by conditional logistic regression for matched case-control sets, fitting fixed-effect and random-effect models with both one- and two-stage approaches.
RESULTS: One- and two-stage approaches gave very similar results, showing uncertainty of TCA-arrhythmia association (random-effect odds ratios [ORs], 95% confidence interval [CI], 1.26, 0.71-2.24, and 1.30, 0.66-2.55, respectively) and statistical evidence for etoricoxib-heart failure association (fixed-effect OR, 95% CI, 1.53, 1.41-1.66, and 1.54, 1.42-1.66, respectively).
CONCLUSION: Our study offers further evidence that two-stage approach generates estimates very similar as those from one-stage approach, even in the case of between-DB exposure heterogeneity and when several covariates must be concurrently considered. As current rules limit the free movement of electronic health data, our findings open the door of treating data within the country where they are generated and then to apply conventional techniques for summarizing estimates, which is the two-stage approach for meta-analysis using individual participant data.
STUDY DESIGN AND SETTING: Two nested case-control studies were carried out for estimating the tricyclic antidepressants (TCAs)-arrhythmia and etoricoxib-heart failure associations, respectively, from the Italian Group for Appropriate Drug Prescription in the Elderly and the European Safety of Non-Steroidal Anti-Inflammatory programs. The associations of interest were modeled by conditional logistic regression for matched case-control sets, fitting fixed-effect and random-effect models with both one- and two-stage approaches.
RESULTS: One- and two-stage approaches gave very similar results, showing uncertainty of TCA-arrhythmia association (random-effect odds ratios [ORs], 95% confidence interval [CI], 1.26, 0.71-2.24, and 1.30, 0.66-2.55, respectively) and statistical evidence for etoricoxib-heart failure association (fixed-effect OR, 95% CI, 1.53, 1.41-1.66, and 1.54, 1.42-1.66, respectively).
CONCLUSION: Our study offers further evidence that two-stage approach generates estimates very similar as those from one-stage approach, even in the case of between-DB exposure heterogeneity and when several covariates must be concurrently considered. As current rules limit the free movement of electronic health data, our findings open the door of treating data within the country where they are generated and then to apply conventional techniques for summarizing estimates, which is the two-stage approach for meta-analysis using individual participant data.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app